These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9108104)

  • 21. Neutralizing antibodies to Haemophilus ducreyi cytotoxin.
    Lagergård T; Purvén M
    Infect Immun; 1993 Apr; 61(4):1589-92. PubMed ID: 8454369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chancroid and Haemophilus ducreyi.
    Morse SA
    Clin Microbiol Rev; 1989 Apr; 2(2):137-57. PubMed ID: 2650859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytolethal distending toxins and activation of DNA damage-dependent checkpoint responses.
    Frisan T; Cortes-Bratti X; Thelestam M
    Int J Med Microbiol; 2002 Feb; 291(6-7):495-9. PubMed ID: 11890549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and characterization of the genes encoding the hemolysin of Haemophilus ducreyi.
    Palmer KL; Munson RS
    Mol Microbiol; 1995 Dec; 18(5):821-30. PubMed ID: 8825086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sodA gene of Haemophilus ducreyi encodes a hydrogen peroxide-inhibitable superoxide dismutase.
    San Mateo LR; Toffer KL; Kawula TH
    Gene; 1998 Jan; 207(2):251-7. PubMed ID: 9511768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution, cloning, characterisation and mutagenesis of sodC, the gene encoding copper/zinc superoxide dismutase, a potential determinant of virulence, in Haemophilus ducreyi.
    Langford PR; Kroll JS
    FEMS Immunol Med Microbiol; 1997 Apr; 17(4):235-42. PubMed ID: 9143881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a WaaF (RfaF) homolog expressed by Haemophilus ducreyi.
    Bauer BA; Lumbley SR; Hansen EJ
    Infect Immun; 1999 Feb; 67(2):899-907. PubMed ID: 9916106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemophilus ducreyi, a cytotoxin-producing bacterium.
    Purvén M; Lagergård T
    Infect Immun; 1992 Mar; 60(3):1156-62. PubMed ID: 1541531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea.
    Shima A; Hinenoya A; Asakura M; Sugimoto N; Tsukamoto T; Ito H; Nagita A; Faruque SM; Yamasaki S
    Infect Immun; 2012 Apr; 80(4):1323-32. PubMed ID: 22252871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin.
    Lagergård T; Lundqvist A; Wising C; Gabrielsson V; Ahlman K
    Vaccine; 2007 May; 25(18):3606-14. PubMed ID: 17289219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi.
    Post DM; Munson RS; Baker B; Zhong H; Bozue JA; Gibson BW
    Infect Immun; 2007 Jan; 75(1):113-21. PubMed ID: 17030566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.
    Vakevainen M; Greenberg S; Hansen EJ
    Infect Immun; 2003 Oct; 71(10):5994-6003. PubMed ID: 14500520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory diagnosis of chancroid using species-specific primers from Haemophilus ducreyi groEL and the polymerase chain reaction.
    Parsons LM; Waring AL; Otido J; Shayegani M
    Diagn Microbiol Infect Dis; 1995 Nov; 23(3):89-98. PubMed ID: 8849652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the Haemophilus ducreyi Ton system in internalization of heme from hemoglobin.
    Elkins C; Totten PA; Olsen B; Thomas CE
    Infect Immun; 1998 Jan; 66(1):151-60. PubMed ID: 9423852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An isogenic haemolysin-deficient mutant of Haemophilus ducreyi lacks the ability to produce cytopathic effects on human foreskin fibroblasts.
    Palmer KL; Goldman WE; Munson RS
    Mol Microbiol; 1996 Jul; 21(1):13-9. PubMed ID: 8843430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine tangled pili expressed by Haemophilus ducreyi are a novel class of pili.
    Brentjens RJ; Ketterer M; Apicella MA; Spinola SM
    J Bacteriol; 1996 Feb; 178(3):808-16. PubMed ID: 8550517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi.
    Gargi A; Tamilselvam B; Powers B; Prouty MG; Lincecum T; Eshraghi A; Maldonado-Arocho FJ; Wilson BA; Bradley KA; Blanke SR
    J Biol Chem; 2013 Mar; 288(11):7492-7505. PubMed ID: 23306199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of Haemophilus ducreyi isolates from different geographical locations.
    Mbwana J; Bölin I; Lyamuya E; Mhalu F; Lagergård T
    J Clin Microbiol; 2006 Jan; 44(1):132-7. PubMed ID: 16390960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers.
    Young RS; Fortney KR; Gelfanova V; Phillips CL; Katz BP; Hood AF; Latimer JL; Munson RS; Hansen EJ; Spinola SM
    Infect Immun; 2001 Mar; 69(3):1938-42. PubMed ID: 11179379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.